Bispecific antibodies
The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed more than 25 years ago. However, initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. A...
| 發表在: | Springer ebooks. |
|---|---|
| 企業作者: | |
| 其他作者: | |
| 格式: | Electronic Resource |
| 語言: | English |
| 出版: |
Berlin, Heidelberg
Springer Berlin Heidelberg
c2011
|
| 主題: | |
| 在線閱讀: | Available for University of the Philippines Diliman via SpringerLink. Click here to access |